{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T20:12:53Z","timestamp":1777752773892,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","award":["G00005068"],"award-info":[{"award-number":["G00005068"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109664","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:56:16Z","timestamp":1771358176000},"page":"109664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Electrophilic warhead engagement and structure-activity relationship of Benzothiazole-based putative covalent inhibitors targeting SARS-CoV-2 Main protease"],"prefix":"10.1016","volume":"173","author":[{"given":"Sofia","family":"Kanwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anees","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Yaqoob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaiji","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umer","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.bioorg.2026.109664_bb0005","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109664_bb0010","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1080\/22221751.2021.1964925","article-title":"A novel SARS-CoV-2 related coronavirus with complex recombination isolated from bats in Yunnan province, China","volume":"10","author":"Li","year":"2021","journal-title":"Emerg. Microbes Infect."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109664_bb0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response","volume":"14","author":"Astuti","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109664_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109664_bb0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev-pathol-052620-121224","article-title":"Comparative pathogenesis of severe acute respiratory syndrome coronaviruses","volume":"19","author":"Zhang","year":"2024","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"issue":"10223","key":"10.1016\/j.bioorg.2026.109664_bb0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.109664_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: emergence, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109664_bb0040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/10408363.2020.1783198","article-title":"The COVID-19 pandemic","volume":"57","author":"Ciotti","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.bioorg.2026.109664_bb0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2013.07.037","article-title":"Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studies","volume":"68","author":"Thanigaimalai","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109664_bb0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.it.2020.03.007","article-title":"Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses","volume":"41","author":"Jiang","year":"2020","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109664_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.apsb.2020.10.006","article-title":"Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator","volume":"11","author":"Bian","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.bioorg.2026.109664_bb0060","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/HYPERTENSIONAHA.120.15256","article-title":"Interaction of SARS-CoV-2 and other coronavirus with ACE (angiotensin-converting enzyme)-2 as their main receptor: therapeutic implications","volume":"76","author":"Davidson","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.bioorg.2026.109664_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114570","article-title":"A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals","volume":"240","author":"Ma","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2026.109664_bb0070","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1016\/j.bmcl.2007.08.031","article-title":"Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors","volume":"17","author":"Ghosh","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"20","key":"10.1016\/j.bioorg.2026.109664_bb0075","doi-asserted-by":"crossref","first-page":"11886","DOI":"10.1128\/JVI.01528-14","article-title":"Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance","volume":"88","author":"Deng","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109664_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115860","article-title":"Protease targeted COVID-19 drug discovery and its challenges: insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors","volume":"29","author":"Amin","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109664_bb0085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1099\/0022-1317-83-3-595","article-title":"Conservation of substrate specificities among coronavirus main proteases","volume":"83","author":"Hegyi","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109664_bb0090","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"Chembiochem"},{"issue":"17","key":"10.1016\/j.bioorg.2026.109664_bb0095","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1080\/07391102.2021.1905549","article-title":"Design and synthesis of novel phe-phe hydroxyethylene derivatives as potential coronavirus main protease inhibitors","volume":"40","author":"Khorsandi","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2026.109664_bb0100","doi-asserted-by":"crossref","first-page":"109026","DOI":"10.1016\/j.bioorg.2025.109026","article-title":"Discovery and evaluation of pyrimidine-2, 4-dione derivatives as novel SARS-CoV-2 Mpro inhibitors with antiviral effect","volume":"165","author":"Rao","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109664_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27072180","article-title":"Thiazole\/thiadiazole\/benzothiazole based thiazolidin-4-one derivatives as potential inhibitors of main protease of SARS-CoV-2","volume":"27","author":"Petrou","year":"2022","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.bioorg.2026.109664_bb0110","doi-asserted-by":"crossref","first-page":"13516","DOI":"10.1021\/acs.jmedchem.3c00777","article-title":"Structure\u2013activity relationship studies of SARS-CoV-2 main protease inhibitors containing 4-fluorobenzothiazole-2-carbonyl moieties","volume":"66","author":"Tsuji","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109664_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.622898","article-title":"Structural basis of potential inhibitors targeting SARS-CoV-2 main protease","volume":"9","author":"Mengist","year":"2021","journal-title":"Front. Chem."},{"issue":"6489","key":"10.1016\/j.bioorg.2026.109664_bb0120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109664_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/v14092075","article-title":"Structural basis for the inhibition of coronaviral main proteases by a benzothiazole-based inhibitor","volume":"14","author":"Hu","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109664_bb0130","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41467-023-36729-0","article-title":"Identification of SARS-CoV-2 Mpro inhibitors containing P1\u20194-fluorobenzothiazole moiety highly active against SARS-CoV-2","volume":"14","author":"Higashi-Kuwata","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109664_bb0135","first-page":"1224","article-title":"Synthesis of some substituted benzothiazole derivaties and its biological activities","volume":"1","author":"Shashank","year":"2009","journal-title":"Int. J. ChemTech Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109664_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2478\/intox-2018-0001","article-title":"Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance","volume":"11","author":"Erhirhie","year":"2018","journal-title":"Interdiscip. Toxicol."},{"key":"10.1016\/j.bioorg.2026.109664_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118144","article-title":"Mitigating SARS-CoV-2\u2013exacerbated neuroinflammation and Alzheimer's pathology: synthesis of quinoline-based dual inhibitors targeting cysteine and aspartyl proteases","volume":"300","author":"Khan","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"7811","key":"10.1016\/j.bioorg.2026.109664_bb0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bioorg.2026.109664_bb0155","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.bbapap.2017.05.009","article-title":"Modeling covalent-modifier drugs","volume":"1865","author":"Awoonor-Williams","year":"2017","journal-title":"Biochim. Biophy. Acta Proteins Proteomics"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109664_bb0160","first-page":"585","article-title":"Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease","volume":"40","author":"Shivanika","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2026.109664_bb0165","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11172-016-1340-0","article-title":"Prediction of human intestinal absorption of drug compounds","volume":"65","author":"Radchenko","year":"2016","journal-title":"Russ. Chem. Bull."},{"issue":"Suppl. 2","key":"10.1016\/j.bioorg.2026.109664_bb0170","first-page":"497","article-title":"Acute oral toxicity","volume":"106","author":"Walum","year":"1998","journal-title":"Environ. Health Perspect."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109664_bb0175","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1365-2036.2007.03307.x","article-title":"Drug hepatotoxicity","volume":"25","author":"Chang","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"26","key":"10.1016\/j.bioorg.2026.109664_bb0180","doi-asserted-by":"crossref","first-page":"16890","DOI":"10.1021\/acsomega.1c01501","article-title":"Anti-covid-19 drug analogues: synthesis of novel pyrimidine thioglycosides as antiviral agents against SARS-COV-2 and avian influenza H5N1 viruses","volume":"6","author":"Abu-Zaied","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.109664_bb0185","series-title":"Test No. 425: acute oral toxicity: up-and-down procedure","author":"Co-operation, O.f.E. and Development","year":"2008"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109664_bb0190","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1039\/D4RA08449G","article-title":"Dihydropyrimidine-2-thione derivatives as SARS-CoV-2 main protease inhibitors: synthesis, SAR and in vitro profiling","volume":"15","author":"Saeed","year":"2025","journal-title":"RSC Adv."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109664_bb0195","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/ci500118s","article-title":"Docking covalent inhibitors: a parameter free approach to pose prediction and scoring","volume":"54","author":"Zhu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109664_bb0200","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/minf.201500040","article-title":"Pred-hERG: a novel web-accessible computational tool for predicting cardiac toxicity","volume":"34","author":"Braga","year":"2015","journal-title":"Mol. Inf."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109664_bb0205","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s11030-022-10523-4","article-title":"Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices","volume":"27","author":"Oyedele","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.109664_bb0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109664_bb0215","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109664_bb0220","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:00:59Z","timestamp":1777464059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826002002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S0045206826002002"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109664","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrophilic warhead engagement and structure-activity relationship of Benzothiazole-based putative covalent inhibitors targeting SARS-CoV-2 Main protease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109664"}}